Resources
Blog: Read the latest post
Biotech Limited Partners: learnings from investing in biotech venture capital funds
December 5, 2024
Limited Partners (LPs) are at the heart of the biotech funding ecosystem—these crucial players ignite the funding flywheel that drives biotech innovation.
VibeCast: Expert interviews
VibeCast is our informational podcast and content series exploring the hottest topics in drug development.
Guests include biotech founders, regulatory experts, drug development executives, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments.
Additional resources
Limited Partners (LPs) are at the heart of the biotech funding ecosystem—these crucial players ignite the funding flywheel that drives biotech innovation.
Let’s explore the four most common use cases for an AI-powered drug pipeline analysis platform and how they support strategic decision-making in biopharma.
Artificial Intelligence (AI) is a broad umbrella of technologies, covering a huge swathe of algorithmic applications.
In the pharmaceutical industry, pipeline analysis plays a vital role in managing and optimizing the drug portfolio. The goal is to provide comprehensive insights into the lifecycle of drug candidates, from discovery through clinical trials to market launch.
As we move through 2024, I’m thrilled with the extraordinary work our team is doing to change how we finance drug development: from funding next-generation therapies to helping others identify the highest potential cures in their development pipelines.
Insilico Medicine’s mission is to extend healthy productive longevity by transforming drug discovery and development with generative artificial intelligence.
Uncover new possibilities with VibeOne
Learn how VibeOne can help you discover your next indication or identify high potential development opportunities in your portfolio.
